Secondary Neoplasm — Trials

Secondary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

14,666 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 551–554 of 554 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00937300	T-cell Based Immunotherapy for Head and Neck Cancer	withdrawn	Phase 1	0	Inge Marie SvaneOTHER	1	Nov 23, 2011	clinicaltrials
NCT01245582	Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients(SECOX)	withdrawn	Phase 3	0	SanofiINDUSTRY	0	Nov 9, 2011	clinicaltrials